MNA Analysis: Abbott And Stryker Make Big Deals In Slow Month
This article was originally published in Clinica
Executive Summary
February 2016 was a slow month for medtech mergers and acquisitions punctuated by three billion-dollar-plus deals.
You may also be interested in...
M&A Deals Analysis: February Sees Billion-Dollar Buys Bite
Despite being a slow month, megadeals abounded in February, as the medtech M&A market saw a hat-trick of billion-dollar deals. Medtech Insight recorded 12 deals for the month, on par with January's volume but down from 16 in February 2016.
Start-Up Spotlight: Apama Medical, Targeting AFib With An RF-Balloon Combo
Founded and led by serial entrepreneur Amr Salahieh, Apama Medical is developing a system that aims to combine the advantages of two approaches for treating atrial fibrillation: point-by-point radiofrequency-based ablation and cryoballoon ablation.
No Surprise As Abbott Cuts Loose Angio-Seal, Femoseal To Terumo
Abbott and St. Jude Medical are to lighten their cardiovascular portfolios – and hopefully facilitate the completion of Abbott's pending $25bn acquisition of St. Jude – by selling three product lines to Terumo. Two of the three product lines to be divested come as little surprise, but one product was acquired by Abbott only earlier this year.